BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1752860)

  • 1. Opportunities for treatment of psychoactive substance use disorders with serotonergic medications.
    Sellers EM; Higgins GA; Tomkins DM; Romach MK; Toneatto T
    J Clin Psychiatry; 1991 Dec; 52 Suppl():49-54. PubMed ID: 1752860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic modification of serotonergic function: drugs for the study and treatment of psychiatric and other disorders.
    Fuller RW
    J Clin Psychiatry; 1986 Apr; 47 Suppl():4-8. PubMed ID: 3514585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of 5-HT3 receptor antagonists in models of dependency and withdrawal.
    Costall B; Domeney AM; Kelly ME; Naylor RJ
    Alcohol Alcohol Suppl; 1993; 2():269-73. PubMed ID: 7748309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of ethanol intake by serotonin uptake inhibitors.
    Naranjo CA; Sellers EM; Lawrin MO
    J Clin Psychiatry; 1986 Apr; 47 Suppl():16-22. PubMed ID: 3007443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of serotonin in therapy of depression and related disorders.
    Fuller RW
    J Clin Psychiatry; 1991 May; 52 Suppl():52-7. PubMed ID: 1674251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possibility of 5-HT3 receptor involvement in alcohol dependence: a microdialysis study of nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption.
    Yoshimoto K; Yayama K; Sorimachi Y; Tani J; Ogata M; Nishimura A; Yoshida T; Ueda S; Komura S
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):311A-319A. PubMed ID: 8986229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
    Bubar MJ; Cunningham KA
    Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT receptors: implications for the neuropharmacology of alcohol and alcoholism.
    Overstreet DH; Rezvani AH; Pucilowski O; Janowsky DS
    Alcohol Alcohol Suppl; 1994; 2():205-10. PubMed ID: 8974337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biobehavioural basis of pharmacologic treatment of alcohol dependence.
    Sellers EM
    Alcohol Alcohol Suppl; 1994; 2():517-21. PubMed ID: 8974377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin and dopamine interactions in psychosis prevention.
    Richtand NM; McNamara RK
    Prog Brain Res; 2008; 172():141-53. PubMed ID: 18772031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin uptake inhibitors: effects on motivated consummatory behaviors.
    Amit Z; Smith BR; Gill K
    J Clin Psychiatry; 1991 Dec; 52 Suppl():55-60. PubMed ID: 1752861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment.
    Overstreet DH; Rezvani AH; Cowen M; Chen F; Lawrence AJ
    Addict Biol; 2006 Sep; 11(3-4):356-73. PubMed ID: 16961764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake.
    Koe BK
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():13-7. PubMed ID: 2175308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses?
    Montgomery SA; Fineberg N
    Br J Psychiatry Suppl; 1989 Dec; (8):63-9. PubMed ID: 2692641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New therapeutic possibilities with drugs affecting serotonin receptors].
    Spigset O
    Tidsskr Nor Laegeforen; 1992 May; 112(13):1700-4. PubMed ID: 1509427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.